Urgent

Acquired C1-inhibitor deficiency angioedema

Angioedema · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Bradykinin-mediated angioedema from acquired C1-esterase inhibitor deficiency (associated with lymphoproliferative and autoimmune disease), presenting like hereditary angioedema with non-pruritic, non-urticarial swelling that does not respond to adrenaline/antihistamines.

Figures & algorithms

Clinical features
Clinical features

Red flags

  • Laryngeal/tongue swelling with airway compromise
  • Rapid progression of swelling
  • Poor response to standard anaphylaxis treatment (points to bradykinin mechanism)

Assessment

Differential diagnosis

  • Hereditary angioedema
  • ACE-inhibitor angioedema
  • Histaminergic (allergic) angioedema
  • Idiopathic angioedema

Investigations

  • C4 (low), C1-inhibitor level and function (low)
  • C1q level (low in acquired, normal in hereditary)
  • Screen for underlying lymphoproliferative/autoimmune disease
  • Serial assessment of airway

Management

  • Assess and protect the airway - involve anaesthetics/ENT early if any laryngeal involvement
  • Recognise that adrenaline, antihistamines and steroids are largely ineffective (but give adrenaline if diagnosis uncertain or airway threatened)
  • Give a specific bradykinin-pathway therapy (C1-inhibitor concentrate, or icatibant)
  • Monitor and support until the attack resolves
  • Investigate for and treat the underlying disorder
  • Refer to immunology for long-term management

Drugs & doses

C1-inhibitor concentrate (plasma-derived) for acute attacks
Icatibant (bradykinin B2-receptor antagonist)
Fresh frozen plasma if specific agents unavailable (contains C1-INH)
Adrenaline only if the diagnosis is uncertain or airway is critically threatened

Disposition

Admit if airway involvement; immunology referral and investigation for underlying disease.

Complications & pitfalls

  • Airway obstruction / asphyxiation
  • Recurrent attacks
  • Delayed diagnosis (treated as allergic)

Exam pearls

  • A low C1q distinguishes acquired from hereditary C1-inhibitor deficiency
  • Lack of response to adrenaline/antihistamines/steroids is a key clue to bradykinin-mediated angioedema
  • Always search for an underlying lymphoproliferative disorder

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.